According to ImmunoGen 's latest financial reports the company's current earnings are $0.28 Billion USD. In 2022 the company made an earning of -$0.22 Billion USD a decrease over its 2021 earnings that were of -$0.13 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$62.78 Million | -71.14% |
2022 | -$0.22 Billion | 72.45% |
2021 | -$0.13 Billion | 495.9% |
2020 | -$21.17 Million | -75.71% |
2019 | -$87.16 Million | -44.88% |
2018 | -$0.16 Billion | 99.42% |
2017 | -$79.29 Million | |
2015 | -$0.11 Billion | 43.7% |
2014 | -$72.6 Million | 135.39% |
2013 | -$30.84 Million | -66.03% |
2012 | -$90.78 Million | 42.86% |
2011 | -$63.54 Million | 16.68% |
2010 | -$54.46 Million | 32.83% |
2009 | -$41 Million | -1.99% |
2008 | -$41.84 Million | 108.61% |
2007 | -$20.06 Million | -10.13% |
2006 | -$22.32 Million | 28.86% |
2005 | -$17.32 Million | 120.33% |
2004 | -$7.86 Million | -61.19% |
2003 | -$20.25 Million | -16.6% |
2002 | -$24.28 Million | 51.86% |
2001 | -$15.99 Million | |
1999 | $0.9 M | -112.68% |
1998 | -$7.1 Million | -13.41% |
1997 | -$8.2 Million | -10.87% |
1996 | -$9.2 Million |